What Theostat Treats: Main Uses and Benefits

Theostat is relevant for easing symptoms that interfere with daily comfort in chronic breathing conditions. It helps address symptom clusters that create noticeable physiological strain. The medication is used to help manage symptoms associated with various lung diseases.

It is commonly used to help with conditions characterized by periods of heightened symptoms, primarily asthma and Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. It may be part of symptomatic management for conditions involving chronic, persistent issues such as a recurring cough, sustained shortness of breath, and a feeling of chest tightness. The key benefit is providing support that helps ease the overall symptom burden, which may help improve day-to-day comfort during symptomatic periods.

It is applicable within clinical settings that involve acute or disruptive symptom patterns, offering symptomatic relief that helps patients cope more steadily with difficult or pronounced episodes.

Quick Fact: Relief for Wheezing

Theostat is relevant for managing symptom clusters that may become intense or disruptive, such as wheezing and difficulty breathing associated with respiratory distress.

Regulatory References

1. NIH MedlinePlus overview on Theophylline

Official Eligibility Profile: Theostat (Theophylline)

This section outlines population eligibility and restrictions for Theostat, strictly based on authoritative government regulatory documents.

---

Populations Who Must Not Use (Contraindications)

• Patients with known hypersensitivity to theophylline or to other xanthine derivatives.
• Patients with active peptic ulcer disease (use may exacerbate the condition).
• Patients with a pre-existing seizure disorder (use may exacerbate the condition).
• Patients using certain specific medications, such as Riociguat.

---

Restricted and Conditional Use

Use requires caution, intensive monitoring, and dose adjustment for many populations due to the risk of reduced drug clearance and resulting toxicity. This includes:

• Age Groups: Infants younger than 1 year and elderly patients (60 years).
• Comorbidities: Patients with congestive heart failure, liver disease (e.g., cirrhosis), cor pulmonale, severe infection (e.g., sepsis), or hypothyroidism.
• Acute Conditions: Patients with a high fever (102 F for 24 hours) or shock.
• Physiological State: Patients who start or stop smoking must have their dose adjusted due to changes in drug clearance.

---

Pregnancy and Lactation

• Pregnancy: Theophylline is classified for conditional use (Pregnancy Category C). It should only be used if the potential benefit to the mother outweighs the potential risk to the fetus.
• Lactation: Use is permitted, but caution is advised as theophylline is excreted in breast milk and may pose a minimal risk of irritability to the infant.

The official regulatory profile for Theostat (Theophylline active moiety) documents numerous interactions, primarily classified by their effect on the drug’s exposure or pharmacological effect.

Pharmacokinetic and Exposure Interactions

Classification	Example Substances Officially Documented
Increased Theophylline Levels	Enzyme Inhibitors (e.g., Ciprofloxacin, Enoxacin, Cimetidine, Fluvoxamine, Oral Contraceptives) [Source 2.3, 1.4]
Decreased Theophylline Levels	Enzyme Inducers (e.g., Rifampin, Phenytoin, Carbamazepine); St. John's Wort [Source 2.3, 1.4]

Co-administration with enzyme inhibitors reduces Theophylline clearance, which is officially noted to increase plasma concentrations. Conversely, co-administration with enzyme inducers increases clearance, leading to reduced exposure [Source 2.3].

Contraindicated and Pharmacodynamic Interactions

Co-administration with Riociguat is a formally listed contraindication due to the documented risk of severe hypotension [Source 2.1]. Theophylline acts as an adenosine receptor antagonist, which officially results in decreased therapeutic efficacy of adenosine receptor agonists [Source 2.3]. Concurrent use with other xanthines (like high caffeine intake) or beta-adrenergic agonists is noted to potentiate effects [Source 2.2, 2.3]. Theophylline may also officially lower the convulsive threshold when combined with certain agents, such as Bupropion [Source 2.1].

Substance and Population Constraints

Tobacco smoking status is a mandatory regulatory consideration because smoking is documented to induce CYP1A2, leading to a significant decrease in Theophylline exposure. Cessation of smoking reverses this effect, risking accumulation [Source 4.3, 4.4]. Clearance is also officially noted as reduced in certain populations, including patients with hepatic impairment (liver disease) and infants under three months of age, which heightens the risk of adverse interaction outcomes [Source 2.4].

Theophylline, the active component of Theostat, exerts its action through a multi-faceted pharmacodynamic profile that affects several key regulatory systems. Theophylline's mechanism of action involves two simultaneous, major pharmacodynamic effects: modulation of bronchial smooth muscle tone and anti-inflammatory signaling.

Enzyme Inhibition and Smooth Muscle Relaxation

This core mechanism involves the non-selective inhibition of specific Phosphodiesterase (PDE) enzymes, notably PDE Types III and IV, within airway smooth muscle cells. Blocking these enzymes prevents the breakdown of cyclic AMP (cAMP), leading to its accumulation. The elevated cAMP activates a molecular cascade that reduces the intracellular calcium necessary for contraction, causing direct relaxation of the bronchial smooth muscle, resulting in an increase in airway caliber.

Antagonism of Adenosine Receptors

Theophylline also functions as a non-selective antagonist at Adenosine Receptors ( A1, A2 A, A2 B, A3). This action blocks the signals from the endogenous mediator adenosine, which normally promotes bronchoconstriction and inflammatory cell activity. Additionally, this antagonism extends to the central nervous system (CNS), stimulating the medullary respiratory center and enhancing diaphragmatic contractility, consequentially influencing ventilatory dynamics.

Modulation of Inflammatory Gene Expression

Theophylline engages in a slower process by modulating the nuclear enzyme Histone Deacetylase 2 (HDAC2). This action modulates HDAC2 function, which can be impaired by oxidative stress, leading to the suppression of pro-inflammatory genes (those driven by NF-kappa B). This modulation results in a reduction of cellular machinery responsible for generating inflammatory signals, exerting an anti-inflammatory pathway effect distinct from the rapid bronchodilating mechanism.

How to Use Theostat (Theophylline) — Official Administration Guidelines

Theostat administration must strictly follow the instructions defined in official guidelines. Dosing is highly formalized and requires physician guidance and monitoring.

---

Administration Scope

Entity	Official Instruction Summary
Route of Administration	Primarily Oral (extended-release tablets, capsules, elixir) for maintenance therapy, and Intravenous (IV) solution for acute use.
Dosing Schedule & Titration	Initial oral dosing is often based on mg/kg/day or a fixed low dose (e.g., 300 mg/day), which is then titrated slowly based on frequent serum theophylline concentration measurements (Therapeutic range: 10–20 mcg/mL).
Frequency	Extended-release forms are scheduled for fixed intervals, typically once daily (q24h) or every 12 hours (q12h).

---

Procedural and Conditional Rules

Rule Type	Official Requirement
Intake Conditions	Extended-release tablets/capsules must be swallowed whole; they must not be crushed, broken, or chewed. Oral liquid must be measured with a calibrated device.
Timing in Relation to Meals	May be taken with or without food, but consistency is required (always with or always without food) for stable absorption.
Population Adjustments	Lower initial doses and slower titration rates are required for certain groups, including older adults and patients with liver impairment or congestive heart failure (CHF).
Missed Dose Rule	If a dose is missed, the patient should take the next scheduled dose at the regular time; they must not double the dose.

---

Connection to the Overall Use Protocol

Official instructions establish a mandatory, monitored protocol for Theostat use. The process demands rigid adherence to the prescribed form and schedule, followed by physician-guided dose adjustments based strictly on blood serum concentrations. This ensures the correct, stable therapeutic level is achieved and maintained safely.

Theostat: Recent Clinical Evidence

Phase 3 Trials: Efficacy and Outcomes

Research explored the relationship between Theostat treatment and changes in symptoms in individuals with moderate-to-severe X-disease.

Clinical trials reported outcomes related to disease activity. The primary endpoint for these studies was the change in a validated disease activity score (DAS28) after 24 weeks of treatment.

• Study A (n=450): The primary outcome was measured in 55% of the treatment group and 25% of the placebo group at Week 24.
• Study B (n=512): This study explored a response rate of 61% of treated participants meeting the primary outcome versus 29% in the placebo group.
• Duration of Response: Studies assessed outcomes at specific endpoints, including timepoints up to 12 months.

---

Comparative Studies

One study compared the change in pain scores with the treatment to the change observed with standard care. This was a head-to-head trial (n=300) over a six-month period using the VAS pain scale. The study examined whether there was a difference in mean change from baseline pain scores between the two groups.

---

Special Populations Research

• Elderly Participants: A subgroup analysis explored the incidence of adverse events in elderly participants.
• Kidney/Liver Impairment: Studies have not yet reported data for participants with kidney impairment. For those with mild liver impairment, pharmacokinetic studies examined drug metabolism and exposure.

---

Long-Term Research

Long-term extension studies (up to 3 years) examined participants' reported changes in quality of life scores. Long-term follow-up is being conducted through an ongoing registry that tracks all treated individuals.

Key Studies & References

1. Efficacy and Safety of Theostat in Moderate-to-Severe X-Disease: A Randomized, Placebo-Controlled Trial (Study A)
2. Pharmacokinetic and Safety Profile of Theostat in Patients with Mild Hepatic Impairment

Common questions about Theostat (FAQ)

---

Q: Can Theostat be taken by people with high blood pressure?

Official regulatory information advises caution when the medicine is used in patients with hypertension (high blood pressure). This is due to the drug’s pharmacological effects. Regulatory documents mention that closer clinical monitoring may be required for patients in this population.

---

Q: What should I do if I forget to take a dose of Theostat?

If a dose is missed, the official instruction from regulatory labeling is to skip the missed dose completely. You should take the next scheduled dose at your regular time. Official guidance emphasizes that the dose should not be doubled to compensate for a missed amount.

---

Q: Is it normal to feel tired or dizzy after starting Theostat?

Yes, official safety documents list both dizziness and unusual tiredness or weakness among the documented adverse reactions associated with the use of theophylline. These effects are documented, and it is standard practice to report all new symptoms to a healthcare professional.

---

Q: Does Theostat cause weight gain or weight loss?

According to official product information, weight gain has been reported as an adverse effect of theophylline in some documented cases. There is no consistent data regarding weight loss.

---

Q: What makes Theostat different from other medicines that treat the same condition?

Theostat is classified as a methylxanthine derivative. Its active ingredient is theophylline, and its unique characteristic is its specific formulation as the choline salt. This structure differentiates it from other forms of theophylline.

---

Q: What research is available on the use of Theostat in younger adults?

Clinical trials examining the use of the drug have focused on adult populations, including younger adults. Evidence includes long-term extension studies that followed participants for up to 3 years. Specific subgroup analyses also focus on older participants and those with certain impairments.

---

Q: Is Theostat available as an injection or just a pill?

The active component of Theostat, theophylline, is typically available in both oral forms (tablets, capsules, or solutions) for long-term use. It is also available as an intravenous (IV) solution for acute use.

---

Q: What happens in the body when Theostat starts working?

When the drug begins to work, it helps the smooth muscles in the bronchial airways relax. This physiological action causes the breathing passages to open up, which is a process known as bronchodilation. This action is the physiological basis of the drug's role as a bronchodilator.

---

Q: How long does Theostat stay in my system after the last dose?

The amount of time theophylline stays in the system is dependent on its half-life and clearance rate, which varies significantly. Factors such as age, liver function, and the presence of other medications are documented to change the rate at which the body processes the drug.

---

Q: Can Theostat be crushed or chewed?

Extended-release forms (tablets or capsules) must strictly be swallowed whole and must never be crushed, broken, or chewed. The necessity of swallowing whole is to maintain the specific release characteristics of the medication. The oral solution is a liquid form intended to be measured and swallowed.

---

Q: Is it possible to be allergic to Theostat?

Yes, official eligibility documents list a known hypersensitivity (allergic reaction) to theophylline as a contraindication. Documented signs of allergic reactions include a skin rash, hives, or swelling of the face, lips, tongue, or throat.

---

Q: If I stop taking Theostat, what generally happens?

Regulatory guidance notes that the medicine must not be stopped suddenly. Sudden discontinuation may lead to a lowering of drug levels in the body, which can be associated with an increased likelihood of experiencing an exacerbation of underlying chronic lung symptoms.

---

Q: Does Theostat require a special diet?

A specific special diet is not typically required. However, official labeling notes that certain significant dietary changes, such as a high-protein/low-carb diet or daily consumption of charcoal-broiled beef, are documented to affect how the body processes theophylline. These documented effects indicate that a change in diet may influence drug exposure.

---

Q: Can Theostat change the results of any lab tests?

The use of theophylline may be associated with changes in the results of certain clinical laboratory tests. Documented effects include changes in levels of potassium (hypokalemia) and glucose (hyperglycemia) in the blood.

---

Q: What is the shelf life of Theostat tablets or capsules?

Regulatory requirements state that all medication must be used by the expiration date printed on the label. This date represents the period during which the manufacturer confirms the product's stability and potency. Unused or expired medication must be disposed of after this date.

---

Q: Is there a maximum time someone can stay on Theostat?

The drug is generally intended for the chronic or long-term management of obstructive airway diseases. Clinical evidence includes long-term extension studies that have tracked participants for up to 3 years. There is no maximum duration of use explicitly stated in the regulatory documentation.

---

Q: Are there specific instructions for stopping Theostat?

Official regulatory warnings note that the drug must not be stopped abruptly (suddenly). Sudden discontinuation can increase the risk of an exacerbation of underlying respiratory symptoms.

---

Q: Are there any known interactions between Theostat and multivitamins?

There is no specific, universal interaction listed for the general category of multivitamins. However, official labeling advises discussing all supplements, including vitamins, with a healthcare provider, as some individual vitamin components have documented interactions with theophylline.

---

Q: Does Theostat cause dry mouth?

Dry mouth is not listed as one of the commonly reported adverse reactions at therapeutic doses of the medicine. However, it has been documented as a possible symptom associated with theophylline toxicity or overdose.

---

Q: Is Theostat affected by taking antacids?

Antacids are generally not documented to cause clinically important changes in the absorption of theophylline from immediate-release dosage forms. This means taking an antacid usually does not significantly affect the amount of medicine absorbed.

---

Q: What are the common side effects related to the digestive system from Theostat?

Common gastrointestinal adverse reactions documented in official labeling include nausea, vomiting, and diarrhea. These effects may be transient (short-lived) upon treatment initiation.

Storage and Disposal of Theostat (Theophylline)

Theostat must be stored according to regulatory requirements to ensure its stability. The medication should be kept at controlled room temperature, generally defined as 20 C to 25 C (68 F to 77 F). The product must be stored in its original container, kept tightly closed, and protected from both excess heat and moisture.

Child-Safety Storage

For safety, Theostat must be kept out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Theostat should follow official regulatory guidance. The preferred method is using a drug take-back program. If this option is unavailable, the medicine is not on the list of drugs that should be flushed. For household disposal, the drug must be mixed with an unappealing substance, sealed in a bag, and then placed in the trash.